"The Rochester Center for Behavioral Medicine is an outpatient behavioral health clinic dedicated to improving the quality of life experience for our patients. RCBM brings together a comprehensive treatment team with a variety of clinical backgrounds and specialties. Working together, we combine the modalities of psychotherapy with medication and nutrition management to alleviate suffering and help people lead happier, more productive lives. RCBM offers a variety of services to children, adolescents, adults and older adults including ADHD, learning disabilities; depression, bipolar disorder, and other mood and anxiety disorders; work-related concerns, family and marital issues; substance abuse, eating disorders, and weight management."

During the past decade, Rochester Center for Behavioral Medicine conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 20 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rochester Center for Behavioral Medicine" #1 sponsor was "Shire" with 16 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored, "Sunovion" with 3 trials sponsored and "Alcobra Ltd." with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Center for Behavioral Medicine" #1 collaborator was "Shire" with 3 trials as a collaborator and "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rochester Center for Behavioral Medicine" are "Attention Deficit Hyperactivity Disorder (ADHD)" (5 trials), "Major Depressive Disorder" (5 trials), "ADHD" (4 trials), "Attention Deficit Hyperactivity Disorder" (4 trials) and "Attention-Deficit/Hyperactivity Disorder" (4 trials). Many other conditions were trialed in "Rochester Center for Behavioral Medicine" in a lesser frequency.

Most popular intervention types in "Rochester Center for Behavioral Medicine" are "Drug" (40 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Lisdexamfetamine dimesylate" (4 trials), "Dasotraline" (3 trials), "SPD489" (3 trials) and "SPD489 (Lisdexamfetamine dimesylate)" (3 trials). Other intervention names were less common.

The vast majority of trials in "Rochester Center for Behavioral Medicine" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Rochester Center for Behavioral Medicine". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Rochester Center for Behavioral Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rochester Center for Behavioral Medicine, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 0 trials that are defined as “Not Applicable".